KRAS and leukemia: Additionally, the survival of BcorKO;KrasG12D/+ mice was significantly reduced compared with KrasG12D/+ controls indicating that Bcor inactivation resulted in functional co-operation with oncogenic Kras to initiate leukemia in vivo [37].